329 related articles for article (PubMed ID: 23222000)
1. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
3. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
4. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
6. Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis.
Dashti SG; English DR; Simpson JA; Karahalios A; Moreno-Betancur M; Biessy C; Rinaldi S; Ferrari P; Tjønneland A; Halkjær J; Dahm CC; Vistisen HT; Menegaux F; Perduca V; Severi G; Aleksandrova K; Schulze MB; Masala G; Sieri S; Tumino R; Macciotta A; Panico S; Hiensch AE; May AM; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Colorado-Yohar S; Ardanaz E; Allen NE; Weiderpass E; Fortner RT; Christakoudi S; Tsilidis KK; Riboli E; Kaaks R; Gunter MJ; Viallon V; Dossus L
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):104-113. PubMed ID: 33008875
[TBL] [Abstract][Full Text] [Related]
7. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study.
Nowosielski K; Pozowski J; Ulman-Włodarz I; Romanik M; Poręba R; Sioma-Markowska U
Neuro Endocrinol Lett; 2012; 33(2):217-23. PubMed ID: 22592205
[TBL] [Abstract][Full Text] [Related]
13. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of markers of insulin resistance and endometrial cancer risk.
Friedenreich CM; Langley AR; Speidel TP; Lau DC; Courneya KS; Csizmadi I; Magliocco AM; Yasui Y; Cook LS
Endocr Relat Cancer; 2012 Dec; 19(6):785-92. PubMed ID: 23033315
[TBL] [Abstract][Full Text] [Related]
15. Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.
Llanos AA; Krok JL; Peng J; Pennell ML; Vitolins MZ; Degraffinreid CR; Paskett ED
Horm Cancer; 2014 Apr; 5(2):98-103. PubMed ID: 24435584
[TBL] [Abstract][Full Text] [Related]
16. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
17. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol.
Dashti SG; Simpson JA; Viallon V; Karahalios A; Moreno-Betancur M; Brasky T; Pan K; Rohan TE; Shadyab AH; Thomson CA; Wild RA; Wassertheil-Smoller S; Ho GYF; Strickler HD; English DR; Gunter MJ
Cancer Med; 2022 Feb; 11(4):1145-1159. PubMed ID: 35048536
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
[TBL] [Abstract][Full Text] [Related]
20. Insulin and endometrial cancer.
Troisi R; Potischman N; Hoover RN; Siiteri P; Brinton LA
Am J Epidemiol; 1997 Sep; 146(6):476-82. PubMed ID: 9290508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
